Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F66Y6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,547
Award facts
- Contract value 100% obligated
- $9,546.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $9,546.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The parent company, Cencora, Inc., also holds a significant IDC with DLA valued at up to $999,999,999.00 through December 31, 2031. Through these contract vehicles, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F66Y6?
SPE2DR26F66Y6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F66Y6 worth?
The government has obligated $9,547 on SPE2DR26F66Y6.
Is contract SPE2DR26F66Y6 an order under another contract?
Yes. SPE2DR26F66Y6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66Y6 competed?
The extent of competition for SPE2DR26F66Y6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award